Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| agilon health, inc.AGL · Entity 4698 | Chief Markets Officer | April 14, 2026 | April 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
agilon health, inc.
Report date April 14, 2026 · Filed April 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 123,421 |
Reported balance
After 2026-04-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-04-14 · Tax withholding · Disposed 104 · Balance 123,421 F1: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. |
| Common StockSEC Table I · non-derivative | Direct | 122,850 |
Reported balance
After 2026-04-15 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-04-15 · Tax withholding · Disposed 571 · Balance 122,850 F1: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. F2: Includes restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
F2: Includes restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 15, 2026 Filed Apr 17, 2026 00:06 UTC | agilon health, inc. AGL · Entity 4698 | Tax withholdingCommon Stock | 571 | $26.88 | $15,348.48 |
DisclosureSEC source: 0001628280-26-025587 · wk-form4_1776384415.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,850 F1 · price: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2026 Filed Apr 17, 2026 00:06 UTC | agilon health, inc. AGL · Entity 4698 | Tax withholdingCommon Stock | 104 | $22.68 | $2,358.72 |
DisclosureSEC source: 0001628280-26-025587 · wk-form4_1776384415.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,421 F1 · price: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 23:39 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 70,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023768 · wk-form4_1775259553.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,525 F3 · shares: Restricted stock units that vest in three equal installments on each anniversary of April 1, 2026, subject to continued employment. F4 · balance_after: Includes restricted stock units. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 23:39 UTC | agilon health, inc. AGL · Entity 4698 | Tax withholdingCommon Stock | 1,664 | $9.75 | $16,224.00 |
DisclosureSEC source: 0001628280-26-023768 · wk-form4_1775259553.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,525 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. F2 · balance_after: The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 20:49 UTC | agilon health, inc. AGL · Entity 4698 | Tax withholdingCommon Stock | 6,348 | $0.60 | $3,808.17 |
DisclosureSEC source: 0001628280-26-016881 · wk-form4_1773262196.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,379,774 F4 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PSUs and does not represent a sale. F5 · balance_after: Includes restricted stock units. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 20:49 UTC | agilon health, inc. AGL · Entity 4698 | PurchaseCommon Stock | 18,448 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-016881 · wk-form4_1773262196.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,386,122 F1 · shares: This award was granted on April 14, 2023 and all remaining performance-based restricted stock units (PSUs) subject to the award vested on March 9, 2026. F2 · shares: The number of PSUs that vested was determined based on agilon health's predetermined Revenue and Adjusted EBITDA goals over a three-year period from January 1, 2023 through December 31, 2025. Total attainment achieved was 42%. F3 · price: Each PSU represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of PSUs in shares of common stock on their scheduled vesting date. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 22:28 UTC | agilon health, inc. AGL · Entity 4698 | PurchaseCommon Stock | 500,000 | $0.60 | $301,050.00 |
DisclosureSEC source: 0001628280-26-014064 · wk-form4_1772576906.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,367,674 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.5671 to $0.6137, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 15, 2025 Filed Apr 17, 2025 00:50 UTC | agilon health, inc. AGL · Entity 4698 | Tax withholdingCommon Stock | 14,641 | $5.53 | $80,964.73 |
DisclosureSEC source: 0001628280-25-018097 · wk-form4_1744851005.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 867,674 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2025 Filed Apr 17, 2025 00:50 UTC | agilon health, inc. AGL · Entity 4698 | Tax withholdingCommon Stock | 3,665 | $5.60 | $20,524.00 |
DisclosureSEC source: 0001628280-25-018097 · wk-form4_1744851005.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 882,315 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 23:38 UTC | agilon health, inc. AGL · Entity 4698 | GrantOptions (Right to buy) · Derivative | 673,077 | $0.00 Strike: $4.08 | $0.00 |
DisclosureSEC source: 0001628280-25-016681 · wk-form4_1743723488.xml · derivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 673,077 Underlying: Common Stock · 673,077 shares Expires 2035-04-01 F3 · derivative.exercise_date: Options that vest in three equal installments on each anniversary of April 1, 2025, subject to continued employment. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 23:38 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 428,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-016681 · wk-form4_1743723488.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 885,980 F1 · shares: Restricted stock units that vest in three equal installments on each anniversary of April 1, 2025, subject to continued employment. F2 · balance_after: Includes restricted stock units. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 22:41 UTC | agilon health, inc. AGL · Entity 4698 | Tax withholdingCommon Stock | 4,143 | $4.05 | $16,779.15 |
DisclosureSEC source: 0001628280-25-013601 · wk-form4_1742337700.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 457,058 F4 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of PSUs and does not represent a sale. F5 · balance_after: Includes restricted stock units. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 22:41 UTC | agilon health, inc. AGL · Entity 4698 | PurchaseCommon Stock | 11,786 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-013601 · wk-form4_1742337700.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 461,201 F1 · shares: This award was granted on April 14, 2022 and all remaining performance-based restricted stock units (PSUs) subject to the award vested on March 14, 2025. F2 · shares: The number of PSUs that vested was determined based on agilon health's predetermined Revenue and Adjusted EBITDA goals over a three-year period from January 1, 2022 through December 31, 2024. Total attainment achieved was 87%. F3 · price: Each PSU represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of PSUs in shares of common stock on their scheduled vesting date. Read SEC document |
| April 15, 2024 Filed Apr 18, 2024 01:39 UTC | agilon health, inc. AGL · Entity 4698 | GrantOptions (Right to buy) · Derivative | 322,879 | $0.00 Strike: $4.46 | $0.00 |
DisclosureSEC source: 0001628280-24-016654 · wk-form4_1713404334.xml · derivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 322,879 Underlying: Common Stock · 322,879 shares Expires 2034-04-15 F4 · derivative.exercise_date: Options that vest in four equal installments on each anniversary of April 15, 2024, subject to continued employment. Read SEC document |
| April 15, 2024 Filed Apr 18, 2024 01:39 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 196,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-016654 · wk-form4_1713404334.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 454,921 F1 · shares: Restricted stock units that vest in four equal installments on each anniversary of April 15, 2024, subject to continued employment. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2024 Filed Apr 18, 2024 01:39 UTC | agilon health, inc. AGL · Entity 4698 | Tax withholdingCommon Stock | 5,506 | $4.95 | $27,254.70 |
DisclosureSEC source: 0001628280-24-016654 · wk-form4_1713404334.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 449,415 F3 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. F2 · balance_after: Includes restricted stock units. Read SEC document |
| March 14, 2024 Filed Mar 19, 2024 00:42 UTC | agilon health, inc. AGL · Entity 4698 | Tax withholdingCommon Stock | 95,266 | $5.23 | $498,241.18 |
DisclosureSEC source: 0001628280-24-011774 · wk-form4_1710808964.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 258,732 F4 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PSUs and does not represent a sale. F5 · balance_after: Includes restricted stock units. Read SEC document |
| March 14, 2024 Filed Mar 19, 2024 00:42 UTC | agilon health, inc. AGL · Entity 4698 | PurchaseCommon Stock | 274,455 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-011774 · wk-form4_1710808964.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 353,998 F1 · shares: This award was granted on April 14, 2021 and all remaining performance-based restricted stock units (PSUs) subject to the award vested on March 14, 2024. F2 · shares: The number of PSUs that vested was determined based on agilon health's predetermined Revenue and Adjusted EBITDA goals over a three-year period from January 1, 2021 through December 31, 2023. Total attainment achieved was 100%. F3 · price: Each PSU represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of PSUs in shares of common stock on their scheduled vesting date. Read SEC document |
| September 13, 2023 Filed Sep 14, 2023 20:37 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 18,750 | $0.00 Strike: $3.79 | $0.00 |
DisclosureSEC source: 0001019056-23-000351 · shaker.xml · derivative · entry 6 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 301,851 Underlying: Common Stock · 18,750 shares Expires 2029-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on February 9, 2019, and became fully vested as of February 9, 2023. Read SEC document |
| September 13, 2023 Filed Sep 14, 2023 20:37 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 18,750 | $18.00 | $337,455.00 |
DisclosureSEC source: 0001019056-23-000351 · shaker.xml · nonDerivative · entry 4 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,543 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan effective September 15, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.67 to $18.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| September 13, 2023 Filed Sep 14, 2023 20:37 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 18,750 | $3.79 | $71,062.50 |
DisclosureSEC source: 0001019056-23-000351 · shaker.xml · nonDerivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 98,293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| September 12, 2023 Filed Sep 14, 2023 20:37 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 18,750 | $0.00 Strike: $3.79 | $0.00 |
DisclosureSEC source: 0001019056-23-000351 · shaker.xml · derivative · entry 5 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 320,601 Underlying: Common Stock · 18,750 shares Expires 2029-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on February 9, 2019, and became fully vested as of February 9, 2023. Read SEC document |
| September 12, 2023 Filed Sep 14, 2023 20:37 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 18,750 | $18.05 | $338,480.63 |
DisclosureSEC source: 0001019056-23-000351 · shaker.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,543 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan effective September 15, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.76 to $18.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| September 12, 2023 Filed Sep 14, 2023 20:37 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 18,750 | $3.79 | $71,062.50 |
DisclosureSEC source: 0001019056-23-000351 · shaker.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 98,293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 20:17 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 18,750 | $0.00 Strike: $3.79 | $0.00 |
DisclosureSEC source: 0001019056-23-000335 · shaker.xml · derivative · entry 6 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 339,351 Underlying: Common Stock · 18,750 shares Expires 2029-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on February 9, 2019, and became fully vested as of February 9, 2023. Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 20:17 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 18,750 | $18.10 | $339,309.38 |
DisclosureSEC source: 0001019056-23-000335 · shaker.xml · nonDerivative · entry 4 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,543 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan effective September 15, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.865 to $18.360, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 20:17 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 18,750 | $3.79 | $71,062.50 |
DisclosureSEC source: 0001019056-23-000335 · shaker.xml · nonDerivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 98,293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 20:17 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 18,750 | $0.00 Strike: $3.79 | $0.00 |
DisclosureSEC source: 0001019056-23-000335 · shaker.xml · derivative · entry 5 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 358,101 Underlying: Common Stock · 18,750 shares Expires 2029-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on February 9, 2019, and became fully vested as of February 9, 2023. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 20:17 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 18,750 | $18.72 | $351,082.50 |
DisclosureSEC source: 0001019056-23-000335 · shaker.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,543 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan effective September 15, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $18.42 to $19.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 20:17 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 18,750 | $3.79 | $71,062.50 |
DisclosureSEC source: 0001019056-23-000335 · shaker.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 98,293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| July 13, 2023 Filed Jul 14, 2023 20:28 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 18,750 | $0.00 Strike: $3.79 | $0.00 |
DisclosureSEC source: 0001019056-23-000311 · shaker.xml · derivative · entry 6 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 376,851 Underlying: Common Stock · 18,750 shares Expires 2029-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on February 9, 2019, and became fully vested as of February 9, 2023. Read SEC document |
| July 13, 2023 Filed Jul 14, 2023 20:28 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 18,750 | $16.93 | $317,424.38 |
DisclosureSEC source: 0001019056-23-000311 · shaker.xml · nonDerivative · entry 4 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,543 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan effective September 15, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $16.4800 to $17.2550, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| July 13, 2023 Filed Jul 14, 2023 20:28 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 18,750 | $3.79 | $71,062.50 |
DisclosureSEC source: 0001019056-23-000311 · shaker.xml · nonDerivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 98,293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| July 12, 2023 Filed Jul 14, 2023 20:28 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 18,750 | $0.00 Strike: $3.79 | $0.00 |
DisclosureSEC source: 0001019056-23-000311 · shaker.xml · derivative · entry 5 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 395,601 Underlying: Common Stock · 18,750 shares Expires 2029-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on February 9, 2019, and became fully vested as of February 9, 2023. Read SEC document |
| July 12, 2023 Filed Jul 14, 2023 20:28 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 18,750 | $16.97 | $318,181.88 |
DisclosureSEC source: 0001019056-23-000311 · shaker.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,543 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan effective September 15, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $16.58 to $17.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| July 12, 2023 Filed Jul 14, 2023 20:28 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 18,750 | $3.79 | $71,062.50 |
DisclosureSEC source: 0001019056-23-000311 · shaker.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 98,293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 20:14 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 18,750 | $0.00 Strike: $3.79 | $0.00 |
DisclosureSEC source: 0001019056-23-000276 · shaker.xml · derivative · entry 12 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 414,351 Underlying: Common Stock · 18,750 shares Expires 2029-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: These options were granted on February 9, 2019, and became fully vested as of February 9, 2023. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 20:14 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 18,750 | $18.73 | $351,103.13 |
DisclosureSEC source: 0001019056-23-000276 · shaker.xml · nonDerivative · entry 8 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,543 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan effective September 15, 2022. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $18.2600 to $19.100, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 20:14 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 18,750 | $3.79 | $71,062.50 |
DisclosureSEC source: 0001019056-23-000276 · shaker.xml · nonDerivative · entry 7 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 20:14 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 1,100 | $0.00 Strike: $3.79 | $0.00 |
DisclosureSEC source: 0001019056-23-000276 · shaker.xml · derivative · entry 11 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 433,101 Underlying: Common Stock · 1,100 shares Expires 2029-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: These options were granted on February 9, 2019, and became fully vested as of February 9, 2023. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 20:14 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 15,799 | $0.00 Strike: $3.79 | $0.00 |
DisclosureSEC source: 0001019056-23-000276 · shaker.xml · derivative · entry 10 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 434,201 Underlying: Common Stock · 15,799 shares Expires 2029-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: These options were granted on February 9, 2019, and became fully vested as of February 9, 2023. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 20:14 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 1,851 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001019056-23-000276 · shaker.xml · derivative · entry 9 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,851 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These options were granted on April 27, 2017, and became fully vested as of September 14, 2021. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 20:14 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 1,100 | $19.17 | $21,084.36 |
DisclosureSEC source: 0001019056-23-000276 · shaker.xml · nonDerivative · entry 6 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,543 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan effective September 15, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.055 to $19.295, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 20:14 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 1,100 | $3.79 | $4,169.00 |
DisclosureSEC source: 0001019056-23-000276 · shaker.xml · nonDerivative · entry 5 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 20:14 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 15,799 | $18.60 | $293,867.72 |
DisclosureSEC source: 0001019056-23-000276 · shaker.xml · nonDerivative · entry 4 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,543 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan effective September 15, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $18.040 to $19.030, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 20:14 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 15,799 | $3.79 | $59,878.21 |
DisclosureSEC source: 0001019056-23-000276 · shaker.xml · nonDerivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,342 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 20:14 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 1,851 | $17.93 | $33,193.61 |
DisclosureSEC source: 0001019056-23-000276 · shaker.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,543 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan effective September 15, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.665 to $18.040, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 20:14 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 1,851 | $3.00 | $5,553.00 |
DisclosureSEC source: 0001019056-23-000276 · shaker.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,394 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| May 16, 2023 Filed May 17, 2023 20:46 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 25,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-23-030241 · doc4.xml · derivative · entry 6 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,851 Underlying: Common Stock · 25,000 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on April 27, 2017, and became fully vested as of September 14, 2021. Read SEC document |
| May 16, 2023 Filed May 17, 2023 20:46 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 25,000 | $23.14 | $578,535.00 |
DisclosureSEC source: 0001209191-23-030241 · doc4.xml · nonDerivative · entry 4 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,543 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan effective September 15, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $22.74 to $23.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.